Physician profile
Derek W Crouch
NPI 1609160019
$3,471.90
in general payments reported to CMS, 2019-2025
38 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $330 · 2021: $507 · 2022: $424 · 2023: $570 · 2024: $650 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.41 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.12 | 2021-2025 | Vraylar, Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.20 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $338.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $294.63 | 2019-2024 | Veozah |
| Lilly USA, LLC | $226.76 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $224.83 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.52 | 2019-2024 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $162.96 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $136.82 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $122.97 | 2020-2022 | |
| Amgen INC. | $84.78 | 2019-2025 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $79.99 | 2020-2024 | Farxiga, Airsupra |
| Abbott Laboratories | $75.95 | 2023-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $61.38 | 2023 | Quviviq |
| Amarin Pharma, INC. | $60.70 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.